Otonomy (OTIC) – Management Comments
-
Otonomy (OTIC) Begins Phase 2 Clinical Trial of OTO-313 in Tinnitus
-
Otonomy (OTIC) Announces Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-413 in Patients with Hearing Loss
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to OTIC Stock Lookup